Ajanta Pharma

BSE: 532331 | NSE: AJANTPHARM
Ajanta Pharma (CIN: L24230MH1979PLC022059) operates in the Pharmaceuticals industry and has been listed in the stock market since 5th Jun 2000. It currents trades on NSE with symbol AJANTPHARM and on BSE with scrip code 532331.
The registered office of the company is Ajanta House, Charkop, Kandivli (W),Mumbai,Maharashtra,400067.

The management team of Ajanta Pharma is led by Mr. Mannalal B. Agrawal who is the Non-Executive - Non Independent Director-Chairperson related to Promoter. Other members of the management team consist of Mr. Madhusudan B. Agrawal (Designation:Executive Director), Arvind K Agrawal (Designation:Chief Financial Officer), Mr. Yogesh M. Agrawal (Designation:Executive Director), Mr. Rajesh M.Agrawal (Designation:Executive Director), Mr. Chandrakant Khetan (Designation:Non-Executive - Independent Director), Mr. K H. Viswanathan (Designation:Non-Executive - Independent Director), Mr. Prabhakar Dalal (Designation:Non-Executive - Independent Director), Mrs. Anjana Grewal (Designation:Non-Executive - Independent Director), Gaurang Shah (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Ajanta Pharma is as below -

BSE 2173 -9 (-0.41%)

BSE

2173 -9 (-0.41%)
Volume: 2,265.00
M. Cap: 18,807.00
P/E: 24.96
Prev. Close: 2,183.80
Day
52 Wk
Symbol is not Traded Today for NSE

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 6,15,28,601 70.51
Foreign Institutions 67,30,938 7.71
NBFC and Mutual Funds 86,69,400 9.93
Central Government 6,55,215 0.75
Others 8,92,897 1.02
General Public 74,75,036 8.57
Financial Institutions 13,09,183 1.50
Total 8,72,61,270 99.99

Financial Data

Consolidated
Figures in crore 2021 2020 2019
Net Sales 2,889.69 2,587.87 2,055.37
Operating Profit 1,024.54 771.60 587.51
Other Income 25.98 92.19 21.08
Interest 8.27 11.91 1.16
Depreciation 116.09 95.72 72.08
Profit Before Tax 900.18 663.97 514.27
Tax 246.31 196.27 127.30
Profit After Tax 653.87 467.70 386.97
Share Capital 17.39 17.54 17.54
Reserves 2,978.24 2,581.33 2,227.67
Net Worth 2,995.63 2,598.87 2,245.21
Loans 53.88 94.74 49.73
Gross Block 2,140.78 1,976.15 1,593.35
Investments 175.67 79.42 77.73
Cash 209.61 205.25 100.51
Debtors 738.43 775.30 459.48
Net Working Capital 1,224.54 1,010.19 777.37
Operating Profit Margin (%) 35.46 29.82 28.58
Net Profit Margin (%) 22.63 18.07 18.83
Earning Per Share (Rs) 75.20 53.33 44.12
Dividend (%) 475.00 650.00 450.00
Dividend Payout 82.90 113.44 79.22
Standalone
Figures in crore 2021 2020 2019
Net Sales 2,718.59 2,196.42 1,772.62
Operating Profit 1,020.48 713.06 583.36
Other Income 103.57 184.20 102.15
Interest 6.90 9.10 0.41
Depreciation 111.49 91.29 69.90
Profit Before Tax 902.09 612.67 513.05
Tax 226.45 171.54 121.29
Profit After Tax 675.64 441.13 391.76
Share Capital 17.39 17.54 17.54
Reserves 2,867.59 2,443.76 2,124.54
Net Worth 2,884.98 2,461.30 2,142.08
Loans 48.43 43.27 13.77
Gross Block 2,086.54 1,926.65 1,555.61
Investments 156.88 85.77 83.00
Cash 151.98 87.85 35.87
Debtors 782.30 734.24 423.38
Net Working Capital 1,149.55 838.42 649.54
Operating Profit Margin (%) 37.54 32.46 32.91
Net Profit Margin (%) 24.85 20.08 22.10
Earning Per Share (Rs) 77.70 50.30 44.67
Dividend (%) 475.00 650.00 450.00
Dividend Payout 82.90 113.44 79.22
Dividend Declared (₹)
The company has declared dividend 15 times between 05 Sep 2001 and 15 Nov 2019, totaling Rs. 87.00 so far. The most recent dividend was declared on 15 Nov 2019 for Rs. 13.
Bonus History
Date Ratio
17 Sep 2013 issue 1:2

Financial Data Graph

The peers of Ajanta Pharma are AUROPHARMA, GLAXO and NECLIFE.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.